ATE364702T1 - Immunogene meningococcale lps und aussenmembranvesikel und impstoff daraus - Google Patents

Immunogene meningococcale lps und aussenmembranvesikel und impstoff daraus

Info

Publication number
ATE364702T1
ATE364702T1 AT93921120T AT93921120T ATE364702T1 AT E364702 T1 ATE364702 T1 AT E364702T1 AT 93921120 T AT93921120 T AT 93921120T AT 93921120 T AT93921120 T AT 93921120T AT E364702 T1 ATE364702 T1 AT E364702T1
Authority
AT
Austria
Prior art keywords
outer membrane
omp
pct
lipopolysaccharide
directed
Prior art date
Application number
AT93921120T
Other languages
English (en)
Inventor
Der Ley Peter Andre Van
Jan Theunis Poolman
Peter Hoogerhout
Original Assignee
Nederlanden Staat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat filed Critical Nederlanden Staat
Application granted granted Critical
Publication of ATE364702T1 publication Critical patent/ATE364702T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
AT93921120T 1992-10-02 1993-07-30 Immunogene meningococcale lps und aussenmembranvesikel und impstoff daraus ATE364702T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9201716A NL9201716A (nl) 1992-10-02 1992-10-02 Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat.

Publications (1)

Publication Number Publication Date
ATE364702T1 true ATE364702T1 (de) 2007-07-15

Family

ID=19861338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93921120T ATE364702T1 (de) 1992-10-02 1993-07-30 Immunogene meningococcale lps und aussenmembranvesikel und impstoff daraus

Country Status (14)

Country Link
US (1) US5705161A (de)
EP (1) EP0680512B1 (de)
JP (1) JPH08501940A (de)
AT (1) ATE364702T1 (de)
AU (1) AU684720B2 (de)
CA (1) CA2146145C (de)
DE (1) DE69334147T2 (de)
DK (1) DK0680512T3 (de)
ES (1) ES2289739T3 (de)
FI (1) FI951535A7 (de)
NL (1) NL9201716A (de)
NO (1) NO321651B1 (de)
PT (1) PT680512E (de)
WO (1) WO1994008021A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
BR9609882A (pt) * 1995-08-04 1999-07-27 Univ Guelph Vacina processos para preparar a mesma para tratar uma doença infecciosa para inserir uma molécula de ácido nucleico em uma célula de marcaç o para administrar um agente terapêutico a um hospedeiro e para triar um antígeno imunogênico de um patógeno uso de uma vesícula de membrana composição farmacêutica sistema de liberação de drogas e vesícula de membrana
US20020028215A1 (en) 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
US6872398B2 (en) * 1995-12-22 2005-03-29 The United States Of America As Represented By The Secretary Of The Army Conjugate vaccine against gram-negative bacterial infections
US6645503B1 (en) * 1998-03-10 2003-11-11 Wyeth Holdings Corporation Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
GB9823978D0 (en) 1998-11-02 1998-12-30 Microbiological Res Authority Multicomponent meningococcal vaccine
US10967045B2 (en) 1998-11-02 2021-04-06 Secretary of State for Health and Social Care Multicomponent meningococcal vaccine
US6514948B1 (en) * 1999-07-02 2003-02-04 The Regents Of The University Of California Method for enhancing an immune response
US6531131B1 (en) 1999-08-10 2003-03-11 The United States Of America As Represented By The Department Of Health And Human Services Conjugate vaccine for Neisseria meningitidis
EP2364726A3 (de) 1999-09-30 2011-11-09 Isis Innovation Limited Impfstoff gegen Neisseria-Infektion
ES2519440T3 (es) * 2000-07-27 2014-11-07 Children's Hospital & Research Center At Oakland Vacunas para la protección de amplio espectro contra enfermedades causadas por Neisseria meningitidis
EP1495039A4 (de) * 2002-03-20 2006-07-26 Univ Emory Neisseria-mutanten, lipooligosaccharide und immunogene zusammensetzungen
RU2364418C2 (ru) * 2002-08-02 2009-08-20 ГлаксоСмитКлайн Байолоджикалз с.а. ВАКЦИННЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ЛИПОПОЛИСАХАРИДЫ ИММУНОТИПА L2 И/ИЛИ L3, ПРОИСХОДЯЩИЕ ИЗ ШТАММА NEISSERIA MENINGITIDIS IgtB-
US20060057160A1 (en) * 2002-08-02 2006-03-16 Ralph Biemans Vaccine composition
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
HUE031886T2 (en) 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
EP1562982B1 (de) 2002-11-15 2010-05-05 Novartis Vaccines and Diagnostics S.r.l. Unerwartete oberflächenproteine in neisseria meningitidis
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
EP2172213B1 (de) 2003-01-30 2013-04-03 Novartis AG Injizierbarer Impfstoff gegen multiple Meningokokken-Serogruppen
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
US7537766B2 (en) * 2004-08-30 2009-05-26 Wyeth Neisseria meningitidis inner core lipo-oligosaccharide epitopes, multivalent conjugates thereof and immunogenic compositions thereof
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
WO2006081259A2 (en) 2005-01-27 2006-08-03 Children's Hospital & Research Center At Oakland Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
CA2654706A1 (en) 2006-06-12 2007-12-21 Nathalie Devos Neisseria meningitidis lipooligosaccharide vaccine
CN102356089B (zh) 2008-02-21 2014-02-19 诺华股份有限公司 脑膜炎球菌fHBP多肽
UA99659C2 (uk) * 2008-05-30 2012-09-10 Дзе Ю.Ес.Ей., Ес Репрезентед Бай Дзе Секретарі Оф Дзе Армі, Он Бехаф Оф Уолтер Рід Армі Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
EP2411048B1 (de) 2009-03-24 2020-05-06 GlaxoSmithKline Biologicals SA Adjuvantierendes meningokokken-faktor-h-bindungsprotein
EP3017826A1 (de) 2009-03-24 2016-05-11 Novartis AG Kombinationen von meningokkoken-faktor-h-bindenden proteinen und pneumokokken-saccharid-konjugaten
CA2761924C (fr) 2009-05-14 2017-10-31 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
WO2010134225A1 (ja) * 2009-05-20 2010-11-25 国立大学法人鳥取大学 部分糖鎖エピトープを用いた、病原性ナイセリア属細菌感染の検出方法およびそれら細菌に対するワクチン
CN102596240B (zh) 2009-08-27 2015-02-04 诺华股份有限公司 包括脑膜炎球菌fHBP序列的杂交多肽
EP2470205A1 (de) 2009-08-27 2012-07-04 Novartis AG Hilfsstoff mit aluminium, oligonukleotid und polykation
CN102724988B (zh) 2009-09-30 2014-09-10 诺华股份有限公司 脑膜炎球菌fHBP多肽的表达
CA2779816A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
AU2011288203A1 (en) 2010-03-18 2012-08-23 Novartis Ag Adjuvanted vaccines for serogroup B meningococcus
AU2011268507B2 (en) 2010-06-25 2014-08-14 Novartis Ag Combinations of meningococcal factor H binding proteins
JP2015505309A (ja) 2011-12-29 2015-02-19 ノバルティス アーゲー 髄膜炎菌ｈ因子結合タンパク質のアジュバントされた組み合わせ
KR20160127104A (ko) 2014-02-28 2016-11-02 글락소스미스클라인 바이오로지칼즈 에스.에이. 변형된 수막구균 fhbp 폴리펩티드
GB201712824D0 (en) 2017-08-10 2017-09-27 Glaxosmithkline Biologicals Sa Multi-functionalized nOMV Conjugates
SG11202100864VA (en) 2018-08-14 2021-02-25 Evercyte Gmbh Target-specific extracellular vesicles
CA3208643A1 (en) 2021-01-18 2022-07-21 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449958B9 (de) * 1988-12-19 2003-05-28 American Cyanamid Company Meningococcales klasse i-aussenmembranprotein-vakzin
NL9101359A (nl) * 1991-08-07 1993-03-01 Nederlanden Staat Nieuw saccharide-peptide-conjugaat, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk saccharide-peptide-conjugaat omvat.

Also Published As

Publication number Publication date
AU4835193A (en) 1994-04-26
FI951535L (fi) 1995-06-01
DE69334147T2 (de) 2008-02-14
EP0680512B1 (de) 2007-06-13
EP0680512A1 (de) 1995-11-08
NL9201716A (nl) 1994-05-02
AU684720B2 (en) 1998-01-08
FI951535A7 (fi) 1995-06-01
DK0680512T3 (da) 2007-10-01
WO1994008021A1 (en) 1994-04-14
NO321651B1 (no) 2006-06-19
JPH08501940A (ja) 1996-03-05
CA2146145A1 (en) 1994-04-14
CA2146145C (en) 2009-10-27
ES2289739T3 (es) 2008-02-01
NO951181D0 (no) 1995-03-28
DE69334147D1 (de) 2007-07-26
NO951181L (no) 1995-06-01
FI951535A0 (fi) 1995-03-31
US5705161A (en) 1998-01-06
PT680512E (pt) 2007-09-25

Similar Documents

Publication Publication Date Title
ATE364702T1 (de) Immunogene meningococcale lps und aussenmembranvesikel und impstoff daraus
WO1990006696A3 (en) Meningococcal class 1 outer-membrane protein vaccine
AU657487B2 (en) Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations
NO943739L (no) Vaksiner inneholdende vesikler basert på ikke-ioniske overflate-aktive midler
FI960309L (fi) Neisseria meningitidis, B-ryhmän ulkomembraanin poriiniproteiinien korkean tason ilmentäminen, puhdistaminen ja uudelleenlaskostaminen
ATE252602T1 (de) Meningokokkus b-epitop ausbildende monoklonale antikoerper und deren verwendung zur herstellung von impfstoffzusammenstellungen
ES2063965T3 (es) Vacunas para haemophilus influenzae no tipificable.
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
BRPI0107679B8 (pt) composição compreendendo vesículas de membrana externa do grupo sérico b de neisseria meningitidis e um componente inorgânico e uso da mesma
AR006999A1 (es) Una composición inmunogénica, terapéutica o profiláctica , que comprende un polipéptido omp106 aislado, un anticuerpo aislado que se liga a dicho polipéptido y una vacuna que lo comprende.
DK55891D0 (da) Matrix med immunomodulerende virkning
Muttilainen et al. TheNeisseria meningitidisouter membrane protein P1 produced inBacillus subtilisand reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes
ATE105189T1 (de) Haemophilus influenzae typ b polysaccharidaussermembranprotein-konjugat als impfstoff.
SE9402880D0 (sv) New peptide derivatives
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
Van Welzijn Jay R. Luly; Megumi Kawai; Or Yat Sun; Paul Wiedeman; Rolf Wagner Abbott Laboratories, Libertyville, IL, United States
AU8113691A (en) The class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties, and vaccines containing same
EP0873136A4 (de) Spezifischer immunstimulierender factor mit hoher fluoreszens und verfahren für dessen verwendung
AU7614798A (en) High level expression, purification and refolding of the Neisseria meningitidis outer membrane group B porin proteins
ZA915629B (en) Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0680512

Country of ref document: EP